Contribution of TCR signaling strength to CD8+T cell peripheral tolerance mechanisms

Journal of Immunology

Volumn 193, Issue 7, 2014, Pages 3409-3416

  Smith, Trevor R F ^a,b   Verdeil, Gregory ^a,c   Marquardt, Kristi ^a   Sherman, Linda A ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b Inovio Pharmaceuticals Inc   (United States)

^c CENTRE D IMMUNOLOGIE DE MARSEILLE LUMINY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; NATURAL KILLER CELL RECEPTOR NKG2A; PROGRAMMED DEATH 1 RECEPTOR; T LYMPHOCYTE RECEPTOR; ANTIGEN; HLA ANTIGEN CLASS 1; LYMPHOCYTE ANTIGEN RECEPTOR; PEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL SURVIVAL; CONTROLLED STUDY; FLOW CYTOMETRY; IMMUNOLOGICAL TOLERANCE; IMMUNOREACTIVITY; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; CYTOLOGY; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; NONOBESE DIABETIC MOUSE; PHYSIOLOGY;

ANIMALS; ANTIGENS; CD8-POSITIVE T-LYMPHOCYTES; HISTOCOMPATIBILITY ANTIGENS CLASS I; IMMUNE TOLERANCE; MICE; MICE, INBRED NOD; MICE, KNOCKOUT; PEPTIDES; RECEPTORS, ANTIGEN, T-CELL;

EID: 84907212541     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1401194     Document Type: Article

References (27)

1. Hogquist, K. A., T. A. Baldwin, and S. C. Jameson. 2005. Central tolerance: learning self-control in the thymus. Nat. Rev. Immunol. 5: 772-782.
2. Yan, J., and M. J. Mamula. 2002. Autoreactive T cells revealed in the normal repertoire: escape from negative selection and peripheral tolerance. J. Immunol. 168: 3188-3194.
3. Redmond, W. L., and L. A. Sherman. 2005. Peripheral tolerance of CD8 T lymphocytes. Immunity 22: 275-284.
4. Schwartz, R. H. 2003. T cell anergy. Annu. Rev. Immunol. 21: 305-334.
5. Sakaguchi, S., K. Wing, and T. Yamaguchi. 2009. Dynamics of peripheral tolerance and immune regulation mediated by Treg. Eur. J. Immunol. 39: 2331-2336.
6. Redmond, W. L., B. C . Marincek, and L. A. Sherman. 2005. Distinct requirements for deletion versus anergy during CD8 T cell peripheral tolerance in vivo. J. Immunol. 174: 2046-2053.
7. Rocha, B., A. Grandien, and A. A. Freitas. 1995. Anergy and exhaustion are independent mechanisms of peripheral T cell tolerance. J. Exp. Med. 181: 993-1003.
8. Lo, D., J. Freedman, S. Hesse, R. D. Palmiter, R. L. Brinster, and L. A. Sherman. 1992. Peripheral tolerance to an islet cell-specific hemagglutinin transgene affects both CD4+ and CD8+ T cells. Eur. J. Immunol. 22: 1013-1022.
9. Lyman, M. A., C. T. Nugent, K. L. Marquardt, J. A. Biggs, E. G. Pamer, and L. A. Sherman. 2005. The fate of low affinity tumor-specific CD8+ T cells in tumor-bearing mice. J. Immunol. 174: 2563-2572.
10. Liu, K., T. Iyoda, M. Saternus, Y. Kimura, K. Inaba, and R. M. Steinman. 2002. Immune tolerance after delivery of dying cells to dendritic cells in situ. J. Exp. Med. 196: 1091-1097.
11. Hartemann-Heurtier, A., L. T. Mars, N. Bercovici, S. Desbois, C. Cambouris, E. Piaggio, J. Zappulla, A. Saoudi, and R. S. Liblau. 2004. An altered selfpeptide with superagonist activity blocks a CD8-mediated mouse model of type 1 diabetes. J. Immunol. 172: 915-922.
12. DeSilva, D. R., W. S. Feeser, E. J. Tancula, and P. A. Scherle. 1996. Anergic T cells are defective in both jun NH2-terminal kinase and mitogen-activated protein kinase sig naling pathways. J. Exp. Med. 183: 2017-2023.
13. Li, W., C. D. Whaley, A. Mondino, and D. L. Mueller. 1996. Blocked signal transduction to the ERK and JNK protein kinases in anergic CD4+ T cells. Science 271: 1272-1276.
14. Nugent, C. T., D. J. Morgan, J. A. Biggs, A. Ko, I. M. Pilip, E. G. Pamer, and L. A. Sherman. 2000. Characterization of CD8+ T lymphocytes that persist after peripheral tolerance to a self antigen expressed in the pancreas. J. Immunol. 164: 191-200.
15. Alam, S. M., G. M. Davies, C. M. Lin, T. Zal, W. Nasholds, S. C. Jameson, K. A. Hogquist, N. R. Gascoigne, and P. J. Travers. 1999. Qualitative and quantitative differences in T cell receptor binding of agonist and antagonist ligands. Immunity 10: 227-237.
16. Hogquist, K. A., S. C. Jameson, and M. J. Bevan. 1995. Strong agonist ligands for the T cell receptor do not mediate positive selection of functional CD8+ T cells. Immunity 3: 79-86.
17. Yachi, P. P., J. Ampudia, T. Zal, and N . R. Gascoigne. 2006. Altered peptide ligands induce delayed CD8-T cell receptor interaction-A role for CD8 in distinguishing antigen quality. Immunity 25: 203-211.
18. Wei, C. H., and L. A. Sherman . 2007. N-terminal trimer extension of nominal CD8 T cell epitopes is sufficient to promote cross-presentation to cognate CD8 T cells in vivo. J. Immunol. 179: 8280-8286.
19. Redmond, W. L., C. H. Wei, H. T. K reuwel, and L. A. Sherman. 2008. The apoptotic pathway contributing to the deletion of naive CD8 T cells during the induction of peripheral tolerance to a cross-presented self-antigen. J. Immunol. 180: 5275-5282.
20. Morgan, D. J., C. T. Nugent, B. J. Raveney, and L. A. Sherman. 2004. In a transgenic model of spontaneous autoimmune diabetes, expression of a protective class II MHC molecule results in thymic deletion of diabetogenic CD 8+ T cells. J. Immunol. 172: 1000-1008.
21. Koniaras, C., F. R. Carbone, W. R. Heath, and A. M. Lew. 1999. Inhibition of naïve class I-restricted T cells by altered peptide ligands. Immunol. Cell Biol. 77: 318-323.
22. Artyomov, M. N., M. Lis, S. Devadas, M. M. Davis, and A. K. Chakraborty. 2010. CD4 and CD8 binding to MHC molecules primarily acts to enhance Lck delivery. Proc. Natl. Acad. Sci. USA 107: 16916-16921.
23. Cobbold, S. P. 2005. T cell tolerance induced by therapeutic antibodies. Philos. Trans. R. Soc. Lond. B Biol. Sci. 360: 1695-1705.
24. Cobbold S.P.,G. Martin,H. Waldmann. 1990. The induction of skin graft tolerance in major histocompatibility complex-mismatched or primed recipients: primed T cells can be tolerized in the periphery with anti-CD4 and anti-CD8 antibodies. Eur. J. Immunol. 20: 2747-2755.
25. Rock, K. L., and L. Shen. 2005. Cross-presentation: underlying mechanisms and role in immune surveillance. Immunol. Rev. 207: 166-183.
26. Gottschalk, R. A., E. Corse, and J. P. Allison. 2010. TCR ligand density and affinity determine peripheral induction of Foxp3 in vivo. J. Exp. Med. 207: 1701-1711.
27. Gottsch alk, R. A., M. M. Hathorn, H. Beuneu, E. Corse, M. L. Dustin, G. Altan-Bonnet, and J. P. Allison. 2012. Distinct influences of peptide-MHC quality and quantity on in vivo T-cell responses. Proc. Natl. Acad. Sci. USA 109: 881-886.